Bisnode divests operations in Nomi

Bisnode has signed an agreement with French Cegedim to divest its operations in Nomi. Nomi targets the sales and marketing departments of pharmaceutical companies, providing information and services related to the Finnish, Swedish, Norwegian and Danish pharmaceuticals markets. The divestment will provide a minor capital gain and is in line with the strategy to refine and focus Bisnode’s offering.

Nomi identifies and delivers value-adding intelligence with knowledge driven business solutions for increased effectiveness in the sales- and marketing departments of the pharmaceutical industry in the Nordic region. The annual revenue is approximately SEK 60 million with 45 employees. “This divestment is in line with our strategy to focus on synergies within the group and our business as a superior provider of digital business information to the European market. We could only see minor benefits from coordination of data collection and data refinement in Nomi’s operations, which was a key factor in the decision to divest.”, says Johan Wall, CEO of Bisnode.

Tags: